Denosumab increases BMD more than zoledronic acid in women who were treated with bisphosphonates.
Many express a preference for weekly or monthly oral bisphosphonate regimens.
Oral bisphosphonates appear to lower the risk for subsequent fracture and mortality after fracture.
Patients with type 2 diabetes may be at higher risk for fracture than indicated by FRAX score.
Many older people unconcerned about or unaware of osteoporosis.
Asian women taking bisphosphonates may have a higher risk for atypical femur fracture than white women.
Treatment improved bone balance and reduced bone turnover.
The sclerostin inhibitor may increase bone strength at the spine and hip in postmenopausal women.
Treatment over 5 years appears to be safe and effective.
Variables included gender and age.
Selective oral cathepsin K inhibitor odanacatib improved bone density in older women with osteoporosis.
PTH (1-84) for 7 years is linked to reduced calcium and calcitriol supplementation.
Denosumab treatment for up to 10 years is linked to persistent reduction in bone turnover and increased BMD.
Higher doses of vitamin D may actually do more harm than good in elderly women.
Three or more cups per day may lower risk for fracture.
Fracture risk may be lower with bisphosphonates in women with diabetes.
Fracture risk may be significantly lower in postmenopausal women with abaloparatide vs. teriparatide or placebo.
While these may serve as predictors, bone mineral density may not.
Endocrinology Advisor Articles
- Diabetic Retinopathy Risk Not Increased With GLP-1 Receptor Agonist Use in T2D
- Concurrent Risk Factors and Microvascular Complications in Type 1 Diabetes
- Higher Risk for Meningioma Linked to GH Treatment, Radiotherapy During Childhood
- Early Treatment Intensification and Faster Glycemic Control in T2D
- Executive Function Predicts T1D Management Into Emerging Adulthood
- Nutraceuticals May Benefit Patients Who Are Statin Intolerant
- Hypertension Treatments: ARBs
- Semaglutide vs Liraglutide for Weight Loss in Patients With Obesity
- Liraglutide May Lower Risk for Foot Amputation in Type 2 Diabetes
- Thyroid Hormone Levels, Body Composition, Insulin Resistance in Euthyroid Patients
- Cochrane Data Release and the Case for "Open Science"
- Rates of Incident Type 2 Diabetes in Chronic Kidney Disease
- Characteristics of Acquired Partial Lipodystrophy With Metabolic Abnormalities
- Poor Glycemic Control Associated With Higher Risk for Dementia in Older Adults With T1D
- Shift Seen From EDs to Urgent Care for Low-Acuity, Acute Care